Cannara Biotech has received the license for cultivation and processing at its one million square foot cultivation and manufacturing facility in Valleyfield, Quebec
"The majority of zones in the recently acquired greenhouse are being repurposed as an indoor facility to achieve the same growing conditions as Cannara's Farnham Facility, home of Tribal, Orchid CBD and Nugz," the Cannara team explains. "In the Company's first quarter in market, product sales surpassed $7M with supply capabilities as the limiting factor. This ready build facility will allow the company to fast-track time to market and will significantly increase product supply bolstering the company's revenues and footprint into new markets."
The first 10,00 plants will be propagated in the first week of November 2021. "The fully licensed and automated Valleyfield Facility outfitted with climate control and growing systems is comprised of 24 independent growing zones. We will continue to strategically activate these zones to meet the significantly growing cannabis demand in Quebec," they continue.
Cannara has redesigned the independent growing zones at the Valleyfield Facility to replicate indoor growing conditions including growing without utilizing the sun and to apply standard operating procedures used at its Farnham Facility to maintain consistency and quality of its product.
"By recreating an indoor environment and growing without natural sunlight, we can achieve absolute consistency and increase our production of premium-grade cannabis products in Valleyfield," said Zohar Krivorot, President & Chief Executive Officer of Cannara Biotech Inc. "Securing the license for Valleyfield in the span of three months since acquisition is a testament of our commitment and determination to grow Cannara. We believe strongly in our model, to deliver the highest quality at some of the most affordable prices to consumers."
For more information: